Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that patients with systemic lupus erythematosus and diffuse hair loss showed non-scarring alopecia without inflammation and a decrease in total hair follicles.

This review discusses the advantages and limitations of various hair loss evaluation methods but reports no new results; it emphasizes the importance of cautious interpretation for these diagnostic tools.

This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.

This article reviews various causes and investigative techniques for different forms of alopecia and reports no new findings.

This article reviews common hair disorders and their normal anatomy and life cycle, but reports no new research findings.

In this observational study, researchers found that acute telogen effluvium, a form of temporary hair loss, occurred in 80 patients following COVID-19 infection, with 70 showing a significant decrease in hair density and trichoscopic signs like peripilar sign and yellow dots.

This study found that low ferritin levels are associated with higher telogen ratios in women with diffuse hair loss, suggesting an important role of ferritin in telogen effluvium diagnosis.

This study found that low dose methotrexate did not increase hair loss in rheumatoid arthritis patients compared to healthy controls, and many patients even showed a reduction in hair fall over the short term.

This article discusses the history taking and clinical examination process for diagnosing alopecia and outlines a diagnostic approach, noting that it reports no new clinical results.

This review discusses common skin appendage diseases, including their pathophysiology and treatments, but does not report new results.

This study found that a marine complex supplement significantly reduced hair shedding and increased hair growth in men with thinning hair over 180 days.

This study concluded that platelet-rich plasma injections significantly improved hair density, thickness, and scalp inflammation in both male and female pattern hair loss, with better outcomes in lower-grade cases.

This study found that treatment improved symptoms and stopped disease progression for 75% of lichen planopilaris patients whose follow-up data were available.

This study found that combining platelet-rich plasma with topical minoxidil improved hair density and patient satisfaction in androgenetic alopecia patients more than minoxidil alone, with no serious adverse events reported.

This report describes a unique case of dyschromatosis universalis in a 10-year-old Haitian male, notable for the presence of a silvery sheen to his scalp hairs and eyelashes, which may represent a variation of the condition.

This study found that autologous platelet-rich plasma treatment significantly increased the number of hairs in male patients with androgenetic alopecia.

This review presents an objective analysis of female androgenetic alopecia, discussing clinical and dermoscopic examination approaches but reports no new clinical findings.

In this study, Pilopeptan® Intensive, a nutritional supplement containing hydrolyzed collagen, Group B vitamins, and zinc, was found to significantly improve hair parameters in telogen effluvium patients, with sustained benefits observed posttreatment, although mild side effects were reported by some participants.

This case report documented alopecia as a rare complication of SARS-CoV-2 infection in a 33-year-old woman, with hair loss improving after treatment.

This study found that patients with telogen effluvium who delayed hair washing or collected shed hair were more likely to have higher clinical severity and increased disease-related economic burdens, suggesting these behaviors can aid clinical assessments.

This study found that patients with telogen effluvium had a higher rate of acute hair loss and lower monocyte counts if they had contracted COVID-19 prior to hair loss onset.

In this study, PRP therapy initially improved hair density in androgenetic alopecia, but effects decreased over time, suggesting additional treatment may be needed for sustained results.

This study found that an alternating inflatable head pad significantly reduced the incidence and severity of occipital pressure ulcers and alopecia in patients undergoing open heart surgery, suggesting improved postoperative nursing and patient quality of life.

This study found that platelet-rich plasma therapy significantly improved hair density and reduced hair shedding in Vietnamese patients with androgenetic alopecia, with high patient satisfaction and minimal side effects.

This study found that platelet-rich plasma therapy may be a useful alternative to 5% topical minoxidil for treating androgenetic alopecia, with differences in the effectiveness and patient satisfaction outcomes observed.

This study found that combining PRP with microneedling was more effective than PRP alone in improving hair growth and patient perception of hair loss in androgenetic alopecia up to Hamilton-Norwood grade 4.

This study found that PRP therapy resulted in better hair growth and patient satisfaction than minoxidil therapy in men with androgenetic alopecia over six months, and patients with higher platelet counts in PRP experienced greater improvement.

This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.

This study found that combining a potent steroid with a vitamin D analogue may offer more convenient treatment for localized alopecia areata than using a superpotent steroid alone, with comparable efficacy but fewer side effects.

This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.